首页> 外文期刊>Clinical and Translational Allergy >A positive serum basophil histamine release assay is a marker for ciclosporin-responsiveness in patients with chronic spontaneous urticaria
【24h】

A positive serum basophil histamine release assay is a marker for ciclosporin-responsiveness in patients with chronic spontaneous urticaria

机译:血清嗜碱性粒细胞组胺释放测定阳性是慢性自发性荨麻疹患者环孢素反应的标志物

获取原文
           

摘要

The electronic records of 398 patients with chronic spontaneous urticaria (CSU) who had had a serum basophil histamine release assay (BHRA) performed as a marker of functional autoantibodies were audited. The BHRA was positive in 105 patients (26.4%). Fifty eight were treated with ciclosporin because they were H1 anti-histamine unresponsive. CSU patients with a positive BHRA were more likely to respond clinically (P
机译:审核了398例慢性自发性荨麻疹(CSU)患者的电子记录,这些患者进行了血清嗜碱性粒细胞组胺释放测定(BHRA)作为功能性自身抗体的标志物。 105例患者中BHRA阳性(26.4%)。 58例接受环孢素治疗,因为它们对H1抗组胺药无反应。 BHRA阳性的CSU患者更有可能在临床上做出反应(P

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号